手性砌块|Chiral Building Blocks-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

手性砌块就是含有手性碳原子的一类有机化合物。

5-(((1R,1aS,6bR)-1-(6-(Trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one 5-(((1R,1aS,6bR)-1-(6-(三氟甲基)-1H-苯并[d]咪唑-2-基)-1a,6b-二氢-1H-环丙并[b]苯并呋喃-5-基)氧基)-3,4-二氢-1,8-萘啶-2(1H)-酮: BJS39035001446090-79-498%; ￥9757.00100mg

1-Ethoxy-4-((4-(trans-4-propylcyclohexyl)phenyl)ethynyl)benzene 1-乙氧基-4-((4-(反式-4-丙基环己基)苯基)乙炔基)苯: BJS7608269116903-48-198+%; ￥1802.00100g

(R)-1,3-Dibenzylpiperazine (R)-1,3-二苄基哌嗪: BJS1949547169458-69-998%; ￥2121.00100mg

(R)-2-(2-Bromophenyl)-4-isopropyl-4,5-dihydrooxazole (R)-2-(2-溴苯基)-4-异丙基-4,5-二氢恶唑: BJS6805847321848-65-197%; ￥872.00250mg

(2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanoic acid (2R,3R,4R,5R)-2,3,5,6-四羟基-4-(((2S,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)己酸: BJS817579196-82-297%; ￥2272.00500g

(S)-6-Chloro-4-hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine 1,1-dioxide (S)-6-氯-4-羟基-2-(3-甲氧基丙基)-3,4-二氢-2H-噻吩并[3,2-e][1,2]噻嗪 1,1-二氧化物: BJS5513000160982-13-895+%; ￥9230.001g

(R)-4-(1-Amino-2,2,2-trifluoroethyl)aniline (R)-4-(1-氨基-2,2,2-三氟乙基)苯胺: BJS65459391213382-95-697%; ￥暂无

(R)-Methyl 2-hydroxypropanoate (R)-2-羟基丙酸甲酯: BJS799934917392-83-598%; ￥99.00100g

(S)-2-(2-Bromophenyl)-4-isopropyl-4,5-dihydrooxazole (S)-2-(2-溴苯基)-4-异丙基-4,5-二氢恶唑: BJS6527316148836-24-297%; ￥546.00250mg

(1S,2R,4S,5R)-1-Benzyl-2-(hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium chloride (1S,2R,4S,5R)-1-苄基-2-(羟基(喹啉-4-基)甲基)-5-乙烯基奎宁-1-鎓氯化物: BJS430197969221-14-399%; ￥1033.005g

(R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate (R)-4-(4-(6-氨基-5-(1-(2,6-二氯-3-氟苯基)乙氧基)吡啶-3-基)-1H-吡唑-1-基)哌啶-1-羧酸叔丁酯: BJS3059849877399-51-495%; ￥15408.001g

(4bR,8aS,9S)-4-Hydroxy-3,7-dimethoxy-11-methyl-9,10-dihydro-5H-9,4b-(epiminoethano)phenanthren-6(8aH)-one (4bR,8aS,9S)-4-羟基-3,7-二甲氧基-11-甲基-9,10-二氢-5H-9,4b-(epiminoethano)菲-6(8aH)-酮: BJS9529282115-53-798+%; ￥7457.005g

(8S,9R,10S,11S,13S,14S,16S,17R)-9-Fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate (8S,9R,10S,11S,13S,14S,16S,17R)-9-氟-11-羟基-17-(2-羟基乙酰基)-10,13,16-三甲基-3-氧代-6,7,8,9,10,11,12,13,14,15,16,17-十二氢-3H-环戊并[a]菲-17-基戊酸酯: BJS10770002152-44-597%; ￥1029.001g

(R)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide (R)-2,4-二羟基-N-(3-羟丙基)-3,3-二甲基丁酰胺: BJS455127781-13-099%; ￥158.00100g

(R)-2-Amino-3-(4-iodophenyl)propan-1-ol (R)-2-氨基-3-(4-碘苯基)丙-1-醇: BJS4215200210554-97-595+%; ￥暂无

(R)-2-Hydroxy-3-phenylpropanoic acid (R)-3-苯基-2-羟丙酸: BJS36580207326-19-497%; ￥59.001g

(E)-1-(2,4-Dihydroxyphenyl)-3-(4-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)prop-2-en-1-one (E)-1-(2,4-二羟基苯基)-3-(4-(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)苯基)丙-2-烯-1-酮: BJS26153945041-81-698%; ￥3816.0050mg

(R)-tert-Butyl (1-aminopropan-2-yl)carbamate (R)-(1-氨基丙烷-2-基)氨基甲酸叔丁酯: BJS4728668100927-10-498%; ￥6416.0025g

(3S,8S,9S,10R,13R,14S,17R)-17-((R)-6-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol (3S,8S,9S,10R,13R,14S,17R)-17-((R)-6-羟基-6-甲基庚-2-基)-10,13-二甲基-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-3-醇: BJS13800732140-46-795%; ￥2806.00100mg

(S)-3-(4-(2-(4-((S)-2-Acetoxy-3-chloropropoxy)phenyl)propan-2-yl)phenoxy)propane-1,2-diyl diacetate (S)-3-(4-(2-(4-((S)-2-乙酰氧基-3-氯丙氧基)苯基)丙-2-基)苯氧基)丙烷-1,2-二基二乙酸酯: BJS49955001637573-04-697%; ￥13637.0050mg

1 2 3 4 5 6 7 8 9 ... 297